Shorts
0:35
The Future of Oncology Innovation is Moving to the Community
7 months ago
by
Jason Hammonds
0:36
Medicaid Expansion Saves Lives in Breast Cancer
7 months ago
by
Oluwasegun Akinyemi, MD, PhD
1:06
Understanding Co-Mutations and Real-Time ctDNA Monitoring in Lung Cancer
7 months ago
by
Estelamari Rodriguez, MD, MPH
0:32
Developing Novel Alpha-Emitting Agents in Prostate Cancer
7 months ago
by
Fred Saad, MD, FRCS
0:33
The Silent Crisis: Why Oncologists are Burning Out
7 months ago
by
Pallav K. Mehta, MD(+1 more)
0:38
The Future of Hybrid Healthcare
7 months ago
by
Pallav K. Mehta, MD(+1 more)
0:31
The Most 'Ripe' Areas for AI in Healthcare Right Now
7 months ago
by
Pallav K. Mehta, MD(+1 more)
0:33
The Challenge Isn't the Medicine—It's the Operations
7 months ago
by
Jason Hammonds
0:33
Predicting the Future: AI in the Medical Clinic
7 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:29
How AI Could Have Saved More Lives 10 Years Ago
7 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:44
How AI is Revolutionizing Precision Oncology
7 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:38
Why Macrophages are the Future of Cancer Therapy
7 months ago
by
Paolo Strati, MD
0:58
Findings From LITESPARK-011 Poised for Treatment Shift in RCC
7 months ago
by
Rahul A. Parikh, MD
0:44
Molecular Profiling and Neoadjuvant Care in Gyn Cancers
7 months ago
by
Erin Crane, MD, MPH
0:43
How Academic and Community Centers Can Better Collaborate on CAR T
7 months ago
by
Marc S. Hoffmann, MD
0:44
Breakthrough in Bladder Cancer: The KEYNOTE-B15 Clinical Trial
7 months ago
by
Rahul A. Parikh, MD
0:40
Closing the Access Gap: The Vital Role of the "Enthusiastic Recommendation"
7 months ago
by
Marc S. Hoffmann, MD
0:50
The Hidden Bias in Medical AI Algorithms
7 months ago
by
Chadi Nabhan, MD, MBA, FACP
0:43
From Charting to Caring: How Technology and Delegation Save Clinician Time
7 months ago
by
Erin Crane, MD, MPH
0:32
The Search for a Functional Cure: Treating IGHV-Mutated CLL
7 months ago
by
Marc S. Hoffmann, MD
0:37
DNA Damage and Repair: Understanding pMMR and HRD in Gyn Cancers
7 months ago
by
Erin Crane, MD, MPH
0:36
Continuous vs Time-Limited: Navigating the Major Shift in CLL Care
7 months ago
by
Marc S. Hoffmann, MD
0:48
Beyond Standard Care: Navigating p53 Aberrant and 17p Deleted CLL
7 months ago
by
Marc S. Hoffmann, MD
0:33
How to Potentially Prevent 44% of Cancer Cases
7 months ago
by
Rebecca Siegel, MPH
0:52
Is Stage IV Lung Cancer Incurable? A New Breakthrough Says Otherwise
8 months ago
by
Saiesh Reddy Voppuru, MD
0:45
Why Healthcare Must Embrace AI or Face Collapse
8 months ago
by
Debra Patt, MD, PhD, MBA
1:06
Why 2026 is a Call to Action for Oncology Innovation
8 months ago
by
Debra Patt, MD, PhD, MBA
1:00
Why Drug Prices Are Actually Rising: The 340B Effect
8 months ago
by
Debra Patt, MD, PhD, MBA
0:41
The Challenges of Treating Systemic Brain Metastases
8 months ago
by
Manmeet Ahluwalia, MD
0:59
From 6 Months to 5 Years: The New Era of Brain Metastasis Survival
8 months ago
by
Manmeet Ahluwalia, MD
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Fast Track Designation to TRE-515 for KRAS G12C NSCLC
2
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
3
NDA Submission Initiated for Zipalertinib Combo in EGFR Exon 20+ NSCLC
4
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
5